- Report
- October 2024
- 190 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 250 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 184 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 175 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- May 2024
- 129 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Clinical Trials
- November 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Drug Pipelines
- April 2024
- 210 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Drug Pipelines
- April 2024
- 100 Pages
Global
From €2852EUR$3,000USD£2,396GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Report
- August 2024
- 150 Pages
Global
From €2651EUR$2,789USD£2,227GBP
- Report
- August 2024
- 150 Pages
Global
From €2651EUR$2,789USD£2,227GBP
- Report
- April 2018
- 470 Pages
Global
From €2852EUR$3,000USD£2,396GBP
- Report
- August 2024
- 136 Pages
China
From €1711EUR$1,800USD£1,438GBP
- Report
- June 2021
- 50 Pages
China
From €2472EUR$2,600USD£2,076GBP
- Report
- May 2021
- 50 Pages
China
From €2472EUR$2,600USD£2,076GBP
- Report
- November 2023
- 224 Pages
Global
From €7130EUR$7,500USD£5,990GBP
- Drug Pipelines
- September 2022
- 30 Pages
Global
From €3090EUR$3,250USD£2,596GBP
- Report
- November 2022
- 117 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- November 2023
- 224 Pages
Global
€4749EUR$4,995USD£3,989GBP

Paclitaxel is a chemotherapy drug used to treat breast cancer. It is a semi-synthetic derivative of the natural product Taxol, which is extracted from the bark of the Pacific yew tree. Paclitaxel works by interfering with the normal process of cell division, preventing cancer cells from dividing and growing. It is typically used in combination with other drugs, such as doxorubicin, to treat advanced stages of breast cancer.
Paclitaxel is available in both intravenous and oral formulations, and is often used in combination with other drugs to treat metastatic breast cancer. It is also used to treat other types of cancer, such as ovarian and lung cancer.
Paclitaxel is marketed by several pharmaceutical companies, including Bristol-Myers Squibb, Pfizer, and Sanofi. It is also available as a generic drug in some countries.
Companies in the Paclitaxel market include Bristol-Myers Squibb, Pfizer, Sanofi, Mylan, Teva Pharmaceuticals, and Apotex. Show Less Read more